Epidemiological and Clinical Research Information Network Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00866736
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Epidemiological and Clinical Research Information Network

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Digestive System Neoplasms (Phase 3)

Gastrointestinal Neoplasms (Phase 3)

Ileus (Phase 2)

Intestinal Neoplasms (Phase 3)

Intestinal Pseudo-Obstruction (Phase 2)

Leukemia (Phase 2)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 3)

Prader-Willi Syndrome (Phase 3)

Stomach Neoplasms (Phase 2)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 9
  • # of Trial APIs: 14